Suspended study tracks Valve-in-Valve outcomes for aortic valve patients
NCT ID NCT04902053
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study follows 50 people who previously received an INSPIRIS RESILIA aortic valve and now need a valve-in-valve procedure because their original valve is not working well. Researchers will track complications like death, stroke, bleeding, and valve movement, as well as how well the new valve expands. The goal is to gather safety and performance data, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Edwards transcatheter aortic valve (TAVR) used in valve-in-valve procedure
- What this could lead to
- If successful, this study could provide data to improve safety and effectiveness of valve-in-valve treatments for patients with failing INSPIRIS RESILIA aortic valves.
- What could go wrong
- This is a small, observational study (50 participants) that is currently suspended. It does not test a new treatment but gathers information, so no direct benefit to participants is guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Orlando
Orlando, Florida, 32803, United States
-
Nyph/Cumc
New York, New York, 10032, United States
-
St. Vincent Hospital
Indianapolis, Indiana, 46290, United States
-
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
University of Florida
Gainesville, Florida, 32611, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Southern California
Los Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could predict clot risk after heart valve surgery
- Could a lower warfarin dose make aortic valve replacement safer?
- New heart valve design aims to simplify replacements and cut risks
- Heart valve mystery: scientists hunt for genetic clues in 1,000 patients
- New heart device under study for aortic valve and aorta repair
- Heart valve bacteria under the microscope: could they cause Post-Surgery problems?